The American pharmaceutical giant Johnson & Johnson is willing to pay US$6.5 billion in its plan to close civil lawsuits in the case of talc identified as carcinogenic. This disbursement would occur over a period of 25 years in those cases due to ovarian problems, which represents 99.75% of the claims, while the rest is linked to mesothelioma, known as “asbestos cancer”, which is addressed by separate.
“This plan is the end of our consensual resolution strategy (for the case) announced in October. Since that date, the group has been working with the lawyers representing the majority of the plaintiffs to find a way out of this litigation.”he explained Erik Haas, vice president of J&J legal affairs officer.
The talc in question is accused of containing asbestos and causing ovarian cancer. Given this, the company continues to reject these allegations, although it withdrew the product from the US market.
“The talc-related lawsuits against the group (J&J) demonstrate the unprecedented impact of baseless lawsuits launched against companies Americans and the extreme resolutions obtained by the plaintiffs“, denounced Haas, who also complained about the “distortion of scientific studies.”
According to the American firm, it has won approximately 95% of the cases tried to date. Furthermore, he notes that, given the historical pace, it would take decades to litigate the remaining cases and, therefore, “the majority of plaintiffs will never have their day in court,” he warns.
Third try
This latest plan presented by Johnson & Johnson It is their third attempt to resolve lawsuits alleging that their talcum powder causes cancer of ovaries. The firm argues that the new offer allows for much better compensation than what plaintiffs could achieve.
Topics that may interest you about Johnson & Johnson:
- Johnson & Johnson buys Shockwave Medical for $13.1 billion
- Johnson & Johnson will submit an application to start trials with a surgical robot
- J&J doubles profits after spinning off personal care business
Source: Gestion
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
